Sunesis Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 26   

Articles published

SNSS 5.16 -0.02 (-0.39%)
price chart
Biotech Volatile Stocks: Agios Pharmaceuticals (NASDAQ:AGIO), Sunesis ...
Agios Pharmaceuticals Inc. (NASDAQ:AGIO) announced preliminary data on Sunday from its Phase 1 study of AG-221, in patients with advanced hematologic malignancies with an isocitrate dehydrogenase-2 mutation.
Related articles »  
Biotechs Took Another Hit: Inovio Pharmaceuticals Inc (INO), Unilife Corp ...
Biotechs Took Another Hit: Inovio Pharmaceuticals Inc (INO), Unilife Corp (UNIS), Sunesis Pharmaceuticals, Inc. (SNSS), LipoScience Inc (LPDX), Raptor Pharmaceutical Corp.
News Recap- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS ...
Las Vegas, NV - April 9, 2014 - (TechSonian) �Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) revealed its financial results for the 4th quarter and year which ended on 31stDecember, 2013.
Stocks to Keep Your Eyes on: Sunesis Pharmaceuticals, Inc. (SNSS), Celldex ...
Las Vegas, NV - March 31, 2014 - (TechSonian) �Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) declared financial results for the 4th quarter and year ended 31stDecember, 2013.
Related articles »  
News Buzz � Sunesis Pharmaceuticals, (NASDAQ:SNSS), Demand Media ...
Manhattan, NY- April 9, 2014 - (Techsonian) �Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) declared the cost of an underwritten public offering of 4,650,000 shares of common stock along with two warrants to purchase one share of the company's common ...
Related articles »  
News Buzz - Jazz Pharmaceuticals plc (JAZZ), Sunesis Pharmaceuticals, Inc ...
Sunesis Pharmaceuticals, Inc. (SNSS) posted that it was financial results for the fourth quarter and year ended December 31, 2013.
Stocks to Track - Northwest Biotherapeutics, Inc (NWBO), Sunesis ...
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) declared the cost of an underwritten public offering of 4,650,000 shares of common stock along with two warrants to purchase one share of the company's common stock.
Related articles »  
Stocks to Keep Your Eyes on: Capstone Turbine Corporation (CPST),Sunesis ...
Sunesis Pharmaceuticals, Inc. (SNSS) declared financial results for the 4th quarter and year ended 31st December, 2013.
Sunesis Announces Presentation of Positive Results From Ongoing MD ...
SOUTH SAN FRANCISCO, Calif., April 8, 2014 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced the presentation of results from an ongoing Phase 1b/2 University of Texas MD Anderson Cancer Center-sponsored trial ...
Related articles »  
Is Now the Time to Invest in Agios Pharmaceuticals, Inc?
Additionally, Sunesis Pharmaceuticals (NASDAQ: SNSS ) recently reported that it is delaying a late-stage data readout for its AML candidate vosaroxin after patients were reported to be surviving longer than expected.
Related articles »